Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis

Rheumatology International

Volumn 31, Issue 1, 2011, Pages 79-84

  Her, Minyoung ^a   Lee, Younjae ^a   Jung, Eunuk ^a   Kim, Taehee ^a   Kim, Dongyook ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Herbal medicine; Systemic lupus erythematosus; Toxic hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HERBACEOUS AGENT; LACTATE DEHYDROGENASE; LIVER ENZYME; TUBERCULOSTATIC AGENT; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ACTIVITY; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; HERBAL MEDICINE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC HEPATITIS;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LIVER; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 78751576092     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1237-4     Document Type: Article

References (19)

1. Hallegua DS, Wallace DJ (2002) Gastrointestinal manifestation and hepatic manifestation. In: Wallace DJ, Hahn BH (eds) Dubois' lupus erythematosus, 6th edn. Lippincott William & Wilkins, Philadelphia, pp 843-861
2. MH Pittler E Ernst 2003 Systematic review: hepatotoxic events associated with herbal medicinal products Aliment Pharmacol Ther 18 451 471 1:STN:280:DC%2BD3svhtFWksA%3D%3D 10.1046/j.1365-2036.2003.01689.x 12950418 (Pubitemid 37152286)
3. F Stickel E Patsenker D Schuppan 2005 Herbal hepatotoxicity J Hepatol 43 901 910 10.1016/j.jhep.2005.08.002 16171893 (Pubitemid 41414517)
4. MC Hochberg 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 1725 1:STN:280:DyaK2svmsVaisw%3D%3D 10.1002/art.1780400928 9324032
5. C Bombardier DD Gladman MB Urowitz D Caron CH Chang 1992 Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE Arthritis Rheum 35 630 640 1:STN:280: DyaK383oslWrtg%3D%3D 10.1002/art.1780350606 1599520
6. G Danan C Benichou 1993 Causality assessment of adverse reactions to drugs-i. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries J Clin Epidemiol 46 1323 1330 1:STN:280:DyaK2c%2FksFOquw%3D%3D 10.1016/0895-4356(93)90101-6 8229110 (Pubitemid 23333873)
7. C Benichou G Danan A Flahault 1993 Causality assessment of adverse reactions to drugs-ii. An original model for validation of drug causality assessment methods: case reports with positive rechallenge J Clin Epidemiol 46 1331 1336 1:STN:280:DyaK2c%2FksFyjsg%3D%3D 10.1016/0895-4356(93)90102-7 8229111 (Pubitemid 23333874)
8. AJ Czaja DK Freese 2002 Diagnosis and treatment of autoimmune hepatitis Hepatology 36 479 497 10.1053/jhep.2002.34944 12143059 (Pubitemid 34810370)
9. T Gibson AR Myers 1981 Subclinical liver disease in systemic lupus erythematosus J Rheumatol 8 752 759 1:STN:280:DyaL38%2FnslyntQ%3D%3D 7310775
10. BA Runyon DR La Brecque S Anuras 1980 The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature Am J Med 69 187 194 1:STN:280:DyaL3c3mtlSlug%3D%3D 10.1016/0002-9343(80)90378-2 7405944 (Pubitemid 10036815)
11. SH Kang JI Kim KH Jeong KH Ko PG Ko S Hwang, et al. 2008 Clinical characteristics of 159 cases of acute toxic hepatitis Korean J Hepatol 14 483 492 10.3350/kjhep.2008.14.4.483 19119243
12. MH Miller MB Urowitz DD Gladman LM Blendis 1984 The liver in systemic lupus erythematosus Q J Med 53 401 409 1:STN:280:DyaL2M%2FhsFCnug%3D%3D 6484120
13. NS Lai RH Lin RS Lai UC Kun SC Leu 2001 Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice with an ancient Chinese herb, Ganoderma tsugae Lupus 10 461 465 1:STN:280:DC%2BD38%2Fis1ynsA%3D%3D 10.1191/096120301678416006 11480842 (Pubitemid 32675044)
14. WM Lee 2003 Drug-induced hepatotoxicity N Engl J Med 349 474 485 1:CAS:528:DC%2BD3sXms1Ogs78%3D 10.1056/NEJMra021844 12890847 (Pubitemid 36910027)
15. Seeff LB (2007) Herbal hepatotoxicity. Clin Liver Dis 11:577-596, vii
16. RJ Andrade M Robles A Fernandez-Castaner S Lopez-Ortega M Lopez-Vega, et al. 2007 Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists World J Gastroenterol 13 329 340 1:CAS:528:DC%2BD2sXitFGgtr0%3D 17230599
17. T Kamiyama T Nouchi S Kojima N Murata T Ikeda C Sato 1997 Autoimmune hepatitis triggered by administration of an herbal medicine Am J Gastroenterol 92 703 704 1:STN:280:DyaK2s3nsVWrsA%3D%3D 9128330
18. RL Rubin 2005 Drug-induced lupus Toxicology 209 135 147 1:CAS:528:DC%2BD2MXitlCisbY%3D 10.1016/j.tox.2004.12.025 15767026 (Pubitemid 40568641)
19. S Chitturi GC Farrell 2000 Herbal hepatotoxicity: an expanding but poorly defined problem J Gastroenterol Hepatol 15 1093 1099 1:STN:280: DC%2BD3MzgsVKkug%3D%3D 10.1046/j.1440-1746.2000.02349.x 11106086